Lipocine Partners with Brazilian Firm to Launch TLANDO®: A New Chapter in Global Expansion
Lipocine Inc., a prominent biopharmaceutical entity dedicated to pioneering treatments for men’s health, has achieved a significant milestone in its global outreach. The company has finalized a licensing and supply agreement for its testosterone replacement therapy,TLANDO®,within Brazil. this strategic alliance is designed to improve access to TLANDO® for Brazilian individuals suffering from hypogonadism, which is marked by insufficient testosterone levels. Through this partnership, Lipocine not only reaffirms its dedication to addressing critical healthcare needs but also positions itself strategically within the burgeoning latin American market. As Lipocine embarks on this promising journey, the ramifications for both the institution and patients in Brazil are significant, representing an vital advancement in the international healthcare arena.
Lipocine’s Global Expansion through…
—-
Author : Olivia Williams
Publish date : 2025-05-06 14:02:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
